| In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases Y Li, C Xu, Q Zhang, JY Liu, RX Tan Journal of ethnopharmacology 98 (3), 329-333, 2005 | 403 | 2005 |
| Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis G Zhang, D Panigrahy, LM Mahakian, J Yang, JY Liu, KS Stephen Lee, ... Proceedings of the national academy of sciences 110 (16), 6530-6535, 2013 | 339 | 2013 |
| Orally bioavailable potent soluble epoxide hydrolase inhibitors SH Hwang, HJ Tsai, JY Liu, C Morisseau, BD Hammock Journal of medicinal chemistry 50 (16), 3825-3840, 2007 | 277 | 2007 |
| Aspergillus fumigatus CY018, an endophytic fungus in Cynodon dactylon as a versatile producer of new and bioactive metabolites JY Liu, YC Song, Z Zhang, L Wang, ZJ Guo, WX Zou, RX Tan Journal of biotechnology 114 (3), 279-287, 2004 | 248 | 2004 |
| Chaetominine, a Cytotoxic Alkaloid Produced by Endophytic Chaetomium sp. IFB-E015 RH Jiao, S Xu, JY Liu, HM Ge, H Ding, C Xu, HL Zhu, RX Tan Organic Letters 8 (25), 5709-5712, 2006 | 227 | 2006 |
| 1-Aryl-3-(1-acylpiperidin-4-yl) urea inhibitors of human and murine soluble epoxide hydrolase: Structure− activity relationships, pharmacokinetics, and reduction of … TE Rose, C Morisseau, JY Liu, B Inceoglu, PD Jones, JR Sanborn, ... Journal of medicinal chemistry 53 (19), 7067-7075, 2010 | 202 | 2010 |
| Synthesis and structure− activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase SH Hwang, KM Wagner, C Morisseau, JY Liu, H Dong, AT Wecksler, ... Journal of medicinal chemistry 54 (8), 3037-3050, 2011 | 180 | 2011 |
| Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model JY Liu, J Yang, B Inceoglu, H Qiu, A Ulu, SH Hwang, N Chiamvimonvat, ... Biochemical pharmacology 79 (6), 880-887, 2010 | 146 | 2010 |
| Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events JY Liu, N Li, J Yang, N Li, H Qiu, D Ai, N Chiamvimonvat, Y Zhu, ... Proceedings of the National Academy of Sciences 107 (39), 17017-17022, 2010 | 145 | 2010 |
| Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II–dependent hypertension A Ulu, TR Harris, C Morisseau, C Miyabe, H Inoue, G Schuster, H Dong, ... Journal of cardiovascular pharmacology 62 (3), 285-297, 2013 | 138 | 2013 |
| Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation JY Liu, HJ Tsai, SH Hwang, PD Jones, C Morisseau, BD Hammock British journal of pharmacology 156 (2), 284-296, 2009 | 119 | 2009 |
| Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis P Sirish, N Li, JY Liu, KSS Lee, SH Hwang, H Qiu, C Zhao, SM Ma, ... Proceedings of the National Academy of Sciences 110 (14), 5618-5623, 2013 | 118 | 2013 |
| Anti-Helicobacter pylori metabolites from Rhizoctonia sp. Cy064, an endophytic fungus in Cynodon dactylon YM Ma, Y Li, JY Liu, YC Song, RX Tan Fitoterapia 75 (5), 451-456, 2004 | 115 | 2004 |
| Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches N Li, JY Liu, V Timofeyev, H Qiu, SH Hwang, D Tuteja, L Lu, J Yang, ... Journal of molecular and cellular cardiology 47 (6), 835-845, 2009 | 112 | 2009 |
| Anti-Helicobacter pylori substances from endophytic fungal cultures Y Li, YC Song, JY Liu, YM Ma, RX Tan World Journal of Microbiology and Biotechnology 21, 553-558, 2005 | 110 | 2005 |
| Pinelloside, an antimicrobial cerebroside from Pinellia ternata JH Chen, GY Cui, JY Liu, RX Tan Phytochemistry 64 (4), 903-906, 2003 | 110 | 2003 |
| Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis G Zhang, D Panigrahy, SH Hwang, J Yang, LM Mahakian, HI Wettersten, ... Proceedings of the National Academy of Sciences 111 (30), 11127-11132, 2014 | 105 | 2014 |
| Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy KSS Lee, JY Liu, KM Wagner, S Pakhomova, H Dong, C Morisseau, ... Journal of medicinal chemistry 57 (16), 7016-7030, 2014 | 99 | 2014 |
| Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models JY Liu, YP Lin, H Qiu, C Morisseau, TE Rose, SH Hwang, ... European Journal of Pharmaceutical Sciences 48 (4-5), 619-627, 2013 | 93 | 2013 |
| Soluble epoxide hydrolase inhibitors and heart failure H Qiu, N Li, JY Liu, TR Harris, BD Hammock, N Chiamvimonvat Cardiovascular therapeutics 29 (2), 99-111, 2011 | 92 | 2011 |
Bruce D. HammockUniversity of California Davis在 ucdavis.edu 的电子邮件经过验证
